Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Mallinckrodt Completes $1.21B Cadence Pharma Deal

By R&D Editors | March 20, 2014

Health care products maker Mallinckrodt said Wednesday it completed its $1.21 billion purchase of Cadence Pharmaceuticals.
 
The companies announced the deal in February and valued the final acquisition at $1.4 billion including Cadence’s debt and other consideration. Mallinckrodt expects purchase to add to its adjusted net income immediately.
 
Cadence makes Ofirmev, an injectable version of the drug acetaminophen, the active ingredient in Tylenol. The company is based in San Diego and it focuses on selling products for use in hospitals. Mallinckrodt has said the deal will make its specialty drug business stronger.
 
Mallinckrodt reported $540 million in revenue in its most recent fiscal quarter, and expects $2.2 billion to $2.3 billion in revenue for the year. The company is based in Dublin and was spun off from Covidien PLC in June.
 
Shares of Mallinckrodt lost $1.04, or $1.5 percent, to $70.22 in morning trading. Its shares had risen more than 38 percent so far this year.
 
Date: March 20, 2014
Source: Associated Press

Related Articles Read More >

IBM’s second-generation, 156-qubit Quantum Heron processors offer reduced error rates, 16× better performance, and 25× faster speeds than 2022 systems. The Heron can run quantum circuits with up to 5,000 two-qubit gate operations using Qiskit—nearly double what IBM achieved in 2023.
Quantum computing edges closer to biotech reality in Moderna-IBM pact
New nanopore sensor paves the way for fast, accurate, low-cost DNA sequencing
E. coli makes Tylenol from plastic waste
2025 R&D layoffs tracker hits 132,075 as Amazon CEO signals AI will cut more jobs
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE